Chemoinformaics analysis of 4-(1-cyclopenten-1-yl)-1-morpholino-1-cyclopentene
Molecular Weight | 219.328 | nRot | 2 |
Heavy Atom Molecular Weight | 198.16 | nRig | 16 |
Exact Molecular Weight | 219.162 | nRing | 3 |
Solubility: LogS | -3.1 | nHRing | 1 |
Solubility: LogP | 2.8 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 39.2847 |
nHD | 0 | BPOL | 24.5133 |
QED | 0.662 |
Synth | 3.579 |
Natural Product Likeliness | 0.035 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.973 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.566 |
MDCK | 0.0000176 |
BBB | 0.717 |
PPB | 0.585011 |
VDSS | 0.946 |
FU | 0.251922 |
CYP1A2-inh | 0.159 |
CYP1A2-sub | 0.262 |
CYP2c19-inh | 0.662 |
CYP2c19-sub | 0.832 |
CYP2c9-inh | 0.239 |
CYP2c9-sub | 0.387 |
CYP2d6-inh | 0.057 |
CYP2d6-sub | 0.854 |
CYP3a4-inh | 0.222 |
CYP3a4-sub | 0.433 |
CL | 9.194 |
T12 | 0.558 |
hERG | 0.021 |
Ames | 0.027 |
ROA | 0.067 |
SkinSen | 0.92 |
Carcinogencity | 0.919 |
EI | 0.702 |
Respiratory | 0.754 |
NR-Aromatase | 0.041 |
Antiviral | Yes |
Prediction | 0.880636 |